Cases: We present three cases of patients admitted for GIbleeding.
2
Maintenance 5-FU was discontinued in one patient because of GIbleeding.
3
GIbleeding is a significant complication of VAD therapy.
4
Conclusions: In ICU patients clinically important GIbleeding is rare, and acid suppressants are frequently used.
5
Co-existing diseases, liver failure, coagulopathy and organ failures are the main risk factors for GIbleeding.
6
Glucocorticoids can induce or propagate peptic ulcers and upper GIbleeding especially in combination with NSAIDs.
7
We performed a retrospective review of GIbleeding episodes for all VADs implanted at our institution.
8
Conclusions: Early EGD may be effective for diagnosis and hemostatic treatment in ICU patients with GIbleeding.
9
We performed a local resection in patients with suspected GIST admitted for emergency treatment for GIbleeding.
10
Background and aims: Lower GIbleeding (LGIB) is a common cause of morbidity and mortality.
11
Five male patients experienced GIbleeding-age 63.6 ±3.64 years.
12
After several episodes of cataclysmic upper GIbleeding a mesentero-portal shunt (MPS) was performed at 10 months.
13
Methods: This prospective, observational study included 111 consecutive hospitalizations of 85 cirrhotic patients admitted for GIbleeding.
14
Methods: We included adults without GIbleeding who were acutely admitted to the intensive care unit (ICU) during a 7-day period.
15
Conclusions: SIRS and organ failure develop in many patients with hepatic cirrhosis hospitalized for upper GIbleeding, and are associated with increased mortality.
16
Recent use of nonsteroidal anti-inflammatory drugs was reported by 58% of patients, and 44% presented with GIbleeding.